Skip to main content

Gems

The Predictive Value of Morning Stiffness

A prospective study evaluated the value and associations with morning stiffness in patients with clinically suspect arthralgia, and found that the presence of morning stiffness increases the odds of inflammation (as detected by CRP and MRI synovitis).

Read Article

ICYMI: 2020 Rheumatology Year in Review

2020 was historic, memorable and game-changing. Under the cloud of COVID-19, there were many significant and memorable advances and setbacks for the rheumatology world. In our accounting of most read articles for 2020, (not surprisingly) 17/20 were COVID-related. Below, are our top news items

Read Article

RheumNow Podcast – As Good As I Ever Was (7.2.2021)

Dr. Jack Cush reviews the news and journal reports from this past week on RheumNow.com.

Read Article

RheumNow Podcast - Speak Up! (6.18.2021)

Dr. Jack Cush talks on education, engagement and the challenge of speaking up, if not first!

Read Article
#EULAR2021: "I am an advocate for smart T2T, not a mathematical T2T approach." - Dr. Filip van den Bosch @RheumNow

Meral K. El Ramahi, MD @MeralElRamahiMD( View Tweet )

RheumNow Live 2021 Now Available for All

RheumNow Live (RNL) for 2021 was held March 20 - 21 in Fort Worth, TX, and now all can partake in the meeting - by video, podcast or by signing up for Tuesday Nite Rheumatology (TNR).



RNL has finished its 3rd year as a hybrid meeting, with the live meeting streamed to hundreds at

Read Article

CDC: Fully Vaccinated Can Shed Masks and Resume Travel

The U.S. Centers for Disease Control and Prevention (CDC) today updated COVID guidance such that fully vaccinated people do not need to wear masks outdoors, can avoid wearing them indoors in most places,

Read Article

RheumNow Podcast – Mistakes with Steroids

Dr Jack Cush gives his spin on this week's RheumNews and Rheum Research from RheumNow.com.

Read Article

RheumNow Podcast – Sweet Lies or Hard Truths? (2.26.2021)

Dr. Jack Cush reviews and discusses the news and Journal reports from the past week on RheumNow.com.

Read Article

2020 Rheumatology Year in Review

2020 was historic, memorable and game-changing. Under the cloud of COVID-19, there were many significant and memorable advances and setbacks for the rheumatology world. In our accounting of most read articles for 2020, (not surprisingly) 17/20 were COVID-related. Below, are our top news items

Read Article

Best of 2020: The Nine Lives of Hydroxychloroquine (Updated)

Hydroxychloroquine is one of many medications frequently used in rheumatology practice. Its remarkable versatility is attested by its routine use in lupus, in patients with an autoimmune coagulopathy, in patients with rheumatoid arthritis, as well as in those with a low-level inflammatory

Read Article

Encouraging Rheumatology Fellowship Match for 2021

JJ Cush and ACR Press Release

The results of the National Residents Matching Program (NRMP) match in rheumatology are out and show that rheumatology fellowship was both competitive and highly sought after.



Rheumatology was among the most competitive of subspecialties, that included Allergy and Immunology,

Read Article

RheumNow Podcast – Back Talk: Questions from Listeners (10.23.20)

Dr. Jack Cush reviews the news, journal reports, survey results and "Back Talk" questions from Rheums.

Read Article

High Burnout Rates Among Rheumatologists

Bergman and colleagues have studied a large cohort of US rheumatologists and found that nearly half meet at least one criterion defining "burnout" among physicians.



While attending the annual rheumatology review meeting in 2019 (Rheumatology Winter Clinical Symposium) 128

Read Article

Clinical Trial Boom or Bust in Severe COVID-19

A number of recently published clinical trials are further defining the efficacy and outcomes of tocilizumab or remdesivir in treating SARs-CoV-2 infection.



Remdesivir

Read Article

TNF Inhibitors or non-TNF Biologics - First Best Choice?

Prospective observational findings from the CORRONA registry of rheumatoid arthritis (RA) patients compared clinical outcomes between initial aggressive therapy using either a tumour necrosis factor inhibitor (TNFi) or a non-TNFi (biological disease-modifying antirheumatic drugs (bDMARDs) and

Read Article

RheumNow Podcast – Bad Disease & Bad Outcomes (10.9.20)

Dr. Jack Cush Reviews the news and journal articles from the past week on RheumNow.com.

Read Article

RheumNow Podcast – The Bad News That’s Fit to Print (8.21.20)

Dr Jack Cush reviews the news and journal reports from the past week on RheumNow: filgotinib rejection, delays in diagnosis, metformin benefits COVID, Abx and IBD, and UPA beats MTX.

Read Article
NY Times article about a "guy and aching legs". 48 yrs old w/ myalgias, wt loss, SOB, sinusitis, high inflammatory markers, pulmonary infiltrates, microscopic hematuria, red & swollen ears; but no fever/chills. You're a rheumatologist, you know the Dx. https://t.co/fbrRMNA5u4 https://t.co/JFOcM0MBxB
Dr. John Cush @RheumNow( View Tweet )

RheumNow Podcast – Why Do We Love Rheumatology Fellows? (8.7.20)

Dr. Jack Cush reviews why we all love our rheumatology fellows and our best advice for them stemming from these articles.

Read Article
Virtual Video Joint Exam Pearl #5: The worst/most ineffective Virtual visits done with the Patient (or MD) driving in their CAR for the virtual visit!! Amazingly I have had a half dozen of these & requested the patient pull over so I could deliver a rheum Citation.

Dr. John Cush @RheumNow( View Tweet )

Virtual Video Joint Exam Pearl #4: Professor Paul Emery was right! THe MCP squeeze (done by the patient) and MTP squeeze is fairly predictive of RA/inflammatory arthritis AND outperforms the "Finger" (distal hand) squeeze. Hence the MCP/MTP is my main squeeze!

Dr. John Cush @RheumNow( View Tweet )

Virtual Video Joint Exam Pearl #1: pain elicited by cervical lateral bending (in someone w/ otherwise normal Cx ROM) is highly correlated with Tender trigger points in the neck region (hence #FM)

Dr. John Cush @RheumNow( View Tweet )

Fighting Hydroxychloroquine Misinformation

JAMA Internal Medicine has posted an Editor's note on the use of hydroxychloroquine for COVID-19; noting the sequence of dysfunction since the president promoted its use on March 21, 2020, when he said “What do you have to lose? I’ll say it again: What do you have to lose? Take it

Read Article

More Rheumatology Fellow Advice from the Mentors

If you’re looking for some great advice to consider or rebuke, here is the generous guidance of nearly two dozen leaders in rheumatology who sincerely offer you their wisdom and best wishes.

Read Article